Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

NCT00157651 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Thrombosis
Bleeding

Interventions

DRUG: warfarin
DRUG: placebo

Sponsor

Hamilton Health Sciences Corporation